HMNC Brain Health Completes Patient Randomization for Phase 2b OLIVE Trial for Major Depressive Disorder 
Managing Medicare Advantage Plan Challenges with Your Hospital’s Swing Bed Program
KENNESAW, GA / ACCESSWIRE / December 16, 2024 / Swing beds can be an important tool for your critical access...
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
STONY BROOK, NY / ACCESSWIRE / December 16, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),...
The Developing Doctor Launches Innovative Course to Empower Physicians in Today’s Healthcare Environment
New Program Aims to Equip Physicians with Essential Skills for Personal and Professional SuccessIowa City, Iowa--(Newsfile Corp. - December 16,...
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
First cable-free, ambulatory ECG that captures the heart’s electrical signals from three distinct directions for high-fidelity data collection and advanced...
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement.CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO),...
Awakn Life Sciences Enters into Binding Letter of Intent for Acquisition of Awakn by Graft Polymer (UK) Plc
Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the...
Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)
- Xyngari (formerly DMT310) is currently being studied in Phase 3 for the treatment of acne, with topline results from...
Avenir Wellness Solutions Announces Global Settlement with Ionic Ventures, Eliminating Convertible Debt
SHERMAN OAKS, CA / ACCESSWIRE / December 16, 2024 / Avenir Wellness Solutions, Inc. ("Avenir" or the "Company") (OTCQB:AVRW), a...
Portland Nurse Brian Scherner Featured in Online Interview on Compassionate Care and Community Health
Brian Scherner shares his perspective on community health in new online feature. PORTLAND, OR / ACCESSWIRE / December 16, 2024...
Hoggan Scientific, LLC, Receives ISO 13485:2016 Recertification for Medical Device Quality Management System
Hoggan Receives Vital Recredentialing for Microfet Product Line SALT LAKE CITY, UTAH / ACCESSWIRE / December 16, 2024 / Hoggan...
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing...
JenaValve Announces First Case for Inclusion in JENA-VAD Registry
Registry seeks to evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System in patients with left ventricular...
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format
The term sheet is non-binding, subject to the execution of a definitive agreement Vancouver, Canada, Dec. 16, 2024 (GLOBE NEWSWIRE)...
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Florida
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 16, 2024...
Neural Therapeutics Announces Changes to Board of Directors and Completion of Debt Settlement
Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"), an ethnobotanical drug discovery company...
Hisense Unveils Award-Winning 110-Inch MiniLED TV in MEA
DUBAI, UAE, Dec. 16, 2024 /PRNewswire/ -- Hisense is thrilled to announce the launch of its groundbreaking 110-inch MiniLED TV,...
NeoPhore appoints Michael Shih as Chief Executive Officer
Highly experienced corporate development leader with a track record of international pharma and biotech deal-makingNew CEO to drive growth strategy to maximise...
Promise Bio Emerges from Stealth with $8.3M Seed Investment to Transform Precision Medicine for Immune-Mediated Diseases
Company unveils breakthrough platform that integrates epiproteomics and AI to identify predictive biomarkers for personalized treatments and support drug development...
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU PatientsResults Expected to Promote Awareness and Adoption of PKU...
Seoul to Host 1,040㎡ ‘Seoul Pavilion’ at CES 2025: “Advancing Global Success for Seoul Startups”
SEOUL, South Korea, Dec. 15, 2024 /PRNewswire/ -- The Seoul Metropolitan Government announced on December 9 that it will operate its...